Risk stratification in decisions about nonsteroidal anti-inflammatory drug cotherapy.
Successful application of risk stratification in decisions about nonsteroidal anti-inflammatory drug (NSAID) therapy could enable patients with a lower baseline risk of gastrointestinal (GI) complications to take a nonspecific generic NSAID and those with greater risk of GI complications to take the cotherapies.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016568:Drugs, Generic; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D018570:Risk Assessment; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D016568:Drugs, Generic